Centiva Capital’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
WCA
PCM
NI
Centiva Capital's HCAT Position: Q2 2025 in Review
Centiva Capital sold out of Health Catalyst (HCAT) in Q2 2025, closing a stake of 17,806 shares — an estimated $80.7K sold.
Centiva Capital first reported a position in HCAT in Q1 2024 and held it in 4 quarters. The position peaked at $349K in Q1 2024. 145 funds tracked by Wall St. Rank hold HCAT as of Q2 2025.
- Centiva Capital reported no remaining Health Catalyst position as of Q2 2025 after selling out during the quarter.
- Centiva Capital sold 17,806 Health Catalyst shares in Q2 2025, an estimated $80.7K.
- Centiva Capital first reported a position in Health Catalyst in Q1 2024 and held it in 4 quarters.
- Centiva Capital's Health Catalyst position peaked at $349K in Q1 2024.
- 145 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2025.
Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.